ImmuCell Corporation is an animal health company. The Company operates in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries segment. ImmuCell has developed products that provide immediate immunity to newborn dairy and beef cattle, and is developing product line extensions of its existing products that address mastitis.
... Show moreType | Public | |
Founded | 1982 | |
HQ | Portland, US | Map |
Website | immucell.com | |
Employee Ratings | More |
Employees (est.) (Jan 2018) | 25 | (+79%) |
Share Price (Feb 2019) | $7.9 | (+6%) |
USD | |
---|---|
Net income (Q3, 2018) | (250.0k) |
Market capitalization (12-Feb-2019) | 43.3m |
Closing stock price (12-Feb-2019) | 7.9 |
Cash (30-Sep-2018) | 2.4m |
USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cost of goods sold | 619.0k | 931.9k | 661.2k | 692.2k | 829.8k | 860.5k | 1.2m | 1.1m | 763.5k | 1.4m | 828.3k | 1.1m | 1.5m | 1.5m | 1.2m |
Sales and marketing expense | 258.2k | 285.3k | 262.7k | 373.6k | 316.3k | 381.7k | 419.0k | 462.3k | 483.7k | 514.5k | 400.4k | 446.7k | 531.9k | 475.2k | 494.7k |
Operating expense total | 258.2k | 285.3k | 262.7k | 373.6k | 316.3k | 381.7k | 419.0k | 462.3k | 483.7k | 514.5k | 400.4k | 446.7k | 531.9k | 1.0m | 494.7k |
EBIT | 12.6k | 40.9k | 214.0k | 626.9k | 699.0k | 21.5k | 50.5k | 918.2k |
USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 2.9m | 2.2m | 1.7m | 1.2m | 1.9m | 2.5m | 4.6m | 3.7m | 4.4m | 4.3m | 3.8m | 2.3m | 3.1m | 2.5m | 2.4m |
Accounts Receivable | 720.0k | 428.4k | 563.6k | 735.0k | 789.2k | 1.5m | 947.3k | 677.2k | 1.0m | 705.0k | 868.9k | 999.9k | 985.2k | 854.0k | |
Inventories | 1.5m | 947.3k | 944.2k | 1.0m | 646.1k | 864.4k | 980.9k | 1.2m | 1.8m | 2.1m | 2.6m | 2.7m | 1.9m | 1.8m | 2.2m |
Current Assets | 7.7m | 6.8m | 6.3m | 6.1m | 5.6m | 8.2m | 13.2m | 13.0m | 12.7m | 10.9m | 8.0m | 6.3m | 6.4m | 5.8m | 6.2m |
USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 268.1k | (13.3k) | (308.1k) | (297.8k) | 573.1k | 924.4k | 452.4k | 443.3k | 478.2k | 584.2k | 365.9k | 26.5k | (221.1k) | (1.0m) | (1.3m) |
Depreciation and Amortization | 295.3k | 113.1k | 228.7k | 333.0k | 245.2k | 380.5k | 173.2k | 387.6k | 590.8k | 218.2k | 430.7k | 641.5k | 284.7k | 570.1k | 952.7k |
Inventories | 158.5k | 259.2k | 262.3k | 167.1k | 299.6k | 81.3k | 2.3k | (245.7k) | (783.2k) | 28.0k | (488.8k) | (605.1k) | 119.8k | 212.8k | (200.2k) |
Accounts Payable | (130.5k) | 22.0k | 15.4k | 4.8k | (157.1k) | (92.3k) | (167.1k) | (190.4k) | (100.7k) | 128.1k | 5.6k | 262.3k | (214.8k) | (299.4k) | (58.5k) |
USD | Y, 2018 |
---|---|
Financial Leverage | 1.5 x |
When was ImmuCell founded?
ImmuCell was founded in 1982.
Who are ImmuCell key executives?
ImmuCell's key executives are Elizabeth L. Williams, David S. Cunningham and Jonathan E. Rothschild.
How many employees does ImmuCell have?
ImmuCell has 25 employees.
Who are ImmuCell competitors?
Competitors of ImmuCell include Cannabis Sativa, CTD Holdings and Enanta Pharmaceuticals.
Where is ImmuCell headquarters?
ImmuCell headquarters is located at 56 Evergreen Dr, Portland.
Where are ImmuCell offices?
ImmuCell has an office in Portland.
How many offices does ImmuCell have?
ImmuCell has 1 office.